GSK5733584 Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

GlaxoSmithKline2

Indications

Cancer2
Solid Tumors1
Tumours, Gynecological1
Neoplasms1

Birmingham, Alabama1 trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

GSK Investigational Site

Phase 1

La Jolla, California1 trial

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors

GSK Investigational Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.